Mucus-invasive bacterial biofilms are identified on the colon mucosa of approximately 50% of colorectal cancer (CRC) patients and approximately 13% of healthy subjects. Here, we test the hypothesis that human colon biofilms comprise microbial communities that are carcinogenic in CRC mouse models. Homogenates of human biofilm-positive colon mucosa were prepared from tumor patients (tumor and paired normal tissues from surgical resections) or biofilm-positive biopsies from healthy individuals undergoing screening colonoscopy; homogenates of biofilm-negative colon biopsies from healthy individuals undergoing screening colonoscopy served as controls. After 12 weeks, biofilm-positive, but not biofilm-negative, human colon mucosal homogenates induced colon tumor formation in 3 mouse colon tumor models (germ-free ApcMinΔ850/+;Il10–/– or ApcMinΔ850/+ and specific pathogen–free ApcMinΔ716/+ mice). Remarkably, biofilm-positive communities from healthy colonoscopy biopsies induced colon inflammation and tumors similarly to biofilm-positive tumor tissues. By 1 week, biofilm-positive human tumor homogenates, but not healthy biopsies, displayed consistent bacterial mucus invasion and biofilm formation in mouse colons. 16S rRNA gene sequencing and RNA-Seq analyses identified compositional and functional microbiota differences between mice colonized with biofilm-positive and biofilm-negative communities. These results suggest human colon mucosal biofilms, whether from tumor hosts or healthy individuals undergoing screening colonoscopy, are carcinogenic in murine models of CRC.
Sarah Tomkovich, Christine M. Dejea, Kathryn Winglee, Julia L. Drewes, Liam Chung, Franck Housseau, Jillian L. Pope, Josee Gauthier, Xiaolun Sun, Marcus Mühlbauer, Xiuli Liu, Payam Fathi, Robert A. Anders, Sepideh Besharati, Ernesto Perez-Chanona, Ye Yang, Hua Ding, Xinqun Wu, Shaoguang Wu, James R. White, Raad Z. Gharaibeh, Anthony A. Fodor, Hao Wang, Drew M. Pardoll, Christian Jobin, Cynthia L. Sears
Title and authors | Publication | Year |
---|---|---|
The Role of the Gut Microbiota in Modulating Signaling Pathways and Oxidative Stress in Glioma Therapies
Krawczyk A, Sladowska GE, Strzalka-Mrozik B |
Cancers | 2025 |
Microbiome and biofilm insights from normal vs tumor tissues in Thai colorectal cancer patients
Yincharoen P, Mordmuang A, Techarang T, Tangngamsakul P, Kaewubon P, Atipairin P, Janwanitchasthaporn S, Goodla L, Karnjana K |
NPJ Precision Oncology | 2025 |
Multiomic spatial atlas shows deleted in malignant brain tumors 1 (DMBT1) glycoprotein is lost in colonic dysplasia
Green EH, Kotrannavar SR, Rutherford ME, Lunnemann HM, Kaur H, Heiser CN, Ding H, Simmons AJ, Liu X, Lacy DB, Washington MK, Shrubsole MJ, Liu Q, Lau KS, Sears CL, Coffey RJ, Drewes JL, Markham NO |
The Journal of Pathology | 2025 |
Multidimensional differences of right- and left-sided colorectal cancer and their impact on targeted therapies
Abdel Hamid M, Pammer LM, Oberparleiter S, Günther M, Amann A, Gruber RA, Mair A, Nocera FI, Ormanns S, Zimmer K, Gerner RR, Kocher F, Vorbach SM, Wolf D, Riedl JM, Huemer F, Seeber A |
NPJ Precision Oncology | 2025 |
Microbiota and cancer: unraveling the significant influence of microbial communities on cancer treatment.
Wilson RP, Rink L, Tükel Ç |
Cancer metastasis reviews | 2025 |
Biofilm formation by the host microbiota: a protective shield against immunity and its implication in cancer.
Montanari E, Bernardo G, Le Noci V, Anselmi M, Pupa SM, Tagliabue E, Sommariva M, Sfondrini L |
Molecular cancer | 2025 |
Cancer microbiota: a focus on tumor-resident bacteria.
Vella G, Rescigno M |
EMBO reports | 2025 |
Keystone pathobionts associated with colorectal cancer promote oncogenic reprograming.
Jones J, Shi Q, Nath RR, Brito IL |
PloS one | 2024 |
The Salivary Microbiome and Predicted Metabolite Production are Associated with Barrett’s Esophagus and High Grade Dysplasia or Adenocarcinoma
Solfisburg QS, Baldini F, Baldwin-Hunter B, Austin GI, Lee HH, Park H, Freedberg DE, Lightdale CJ, Korem T, Abrams JA |
Cancer epidemiology, biomarkers & prevention | 2024 |
Bacterial accumulation in intestinal folds induced by physical and biological factors.
Yang J, Isaka T, Kikuchi K, Numayama-Tsuruta K, Ishikawa T |
BMC Biology | 2024 |
Fungi and tumors: The role of fungi in tumorigenesis (Review).
Cheng W, Li F, Gao Y, Yang R |
International journal of oncology | 2024 |
Intestinal Dysbiosis: Microbial Imbalance Impacts on Colorectal Cancer Initiation, Progression and Disease Mitigation
Garvey M |
Biomedicines | 2024 |
Pollutants, microbiota and immune system: frenemies within the gut
Rio P, Gasbarrini A, Gambassi G, Cianci R |
Frontiers in public health | 2024 |
Characteristics of gut microbiome in patients with pediatric solid tumor
Du X, Cui X, Fan R, Pan J, Cui X |
Frontiers in Pediatrics | 2024 |
Intestinal biofilms: pathophysiological relevance, host defense, and therapeutic opportunities.
Jandl B, Dighe S, Gasche C, Makristathis A, Muttenthaler M |
Clinical microbiology reviews | 2024 |
Gut Microbiome and colorectal cancer: discovery of bacterial changes with metagenomics application in Turkısh population.
Ulger Y, Delik A, Akkız H |
Genes & genomics | 2024 |
Escherichia coli on colorectal cancer: A two‐edged sword
Jian C, Yinhang W, Jing Z, Zhanbo Q, Zefeng W, Shuwen H |
Microbial Biotechnology | 2024 |
Fluoroquinolones and Biofilm: A Narrative Review
Geremia N, Giovagnorio F, Colpani A, De Vito A, Botan A, Stroffolini G, Toc DA, Zerbato V, Principe L, Madeddu G, Luzzati R, Parisi SG, Di Bella S |
Pharmaceuticals | 2024 |
Microbiota-induced S100A11-RAGE axis underlies immune evasion in right-sided colon adenomas and is a therapeutic target to boost anti-PD1 efficacy
Zhou Q, Lei L, Cheng J, Chen J, Du Y, Zhang X, Li Q, Li C, Deng H, Wong CC, Zhuang B, Li G, Bai X |
Gut | 2024 |
Microbial dynamics with CRC progression: a study of the mucosal microbiota at multiple sites in cancers, adenomatous polyps, and healthy controls
Senthakumaran T, Moen AE, Tannæs TM, Endres A, Brackmann SA, Rounge TB, Bemanian V, Tunsjø HS |
European Journal of Clinical Microbiology & Infectious Diseases | 2023 |
Seminars in immunology special issue: Nutrition, microbiota and immunity The unexplored microbes in health and disease.
Plitt T, Faith JJ |
Seminars in Immunology | 2023 |
Genetic heterogeneity of colorectal cancer and the microbiome
Senchukova MA |
World journal of gastrointestinal oncology | 2023 |
Keystone pathobionts associated with colorectal cancer promote oncogenic reprograming
Jones J, Shi Q, Nath RR, Brito IL |
2023 | |
Crosstalk between microbial biofilms in the gastrointestinal tract and chronic mucosa diseases
Wang Y, Xu S, He Q, Sun K, Wang X, Zhang X, Li Y, Zeng J |
Frontiers in microbiology | 2023 |
A consortia of clinical E. coli strains with distinct in-vitro adherent/invasive properties establish their own co-colonization niche and shape the intestinal microbiota in inflammation-susceptible mice
Bleich RM, Li C, Sun S, Barlogio CJ, Broberg CA, Franks AR, Bulik-Sullivan E, Dogan B, Simpson KW, Carroll IM, Fodor AA, Arthur JC |
Research square | 2023 |
Gut OncoMicrobiome Signatures (GOMS) as next-generation biomarkers for cancer immunotherapy.
Thomas AM, Fidelle M, Routy B, Kroemer G, Wargo JA, Segata N, Zitvogel L |
Nature reviews. Clinical oncology | 2023 |
Differences in tissue-associated bacteria between metastatic and non-metastatic colorectal cancer
Zhou P, Dai Z, Xie Y, Li T, Xu Z, Huang Y, Sun D, Zhou Y |
Frontiers in microbiology | 2023 |
Colon Cancer Risk Following Intestinal Clostridioides difficile Infection: A Longitudinal Cohort Study.
Geier DA, Geier MR |
Journal of clinical medicine research | 2023 |
The Salivary Microbiome and Predicted Metabolite Production are Associated with Progression from Barrett’s Esophagus to Esophageal Adenocarcinoma
Solfisburg QS, Baldini F, Baldwin-Hunter BL, Lee HH, Park H, Freedberg DE, Lightdale CJ, Korem T, Abrams JA |
2023 | |
Could Microplastics Be a Driver for Early Onset Colorectal Cancer?
Li S, Keenan JI, Shaw IC, Frizelle FA |
Cancers | 2023 |
Impact of Colorectal Cancer Sidedness and Location on Therapy and Clinical Outcomes: Role of Blood-Based Biopsy for Personalized Treatment.
Waldstein S, Spengler M, Pinchuk IV, Yee NS |
Journal of Personalized Medicine | 2023 |
Biofilm and Cancer: Interactions and Future Directions for Cancer Therapy
Choi E, Murray B, Choi S |
International journal of molecular sciences | 2023 |
Bacterial biofilms in the human body: prevalence and impacts on health and disease
Perry EK, Tan MW |
Frontiers in Cellular and Infection Microbiology | 2023 |
The microbial landscape of colorectal cancer.
White MT, Sears CL |
Nature reviews. Microbiology | 2023 |
Bacterial Oncotraits Rather than Spatial Organization Are Associated with Dysplasia in Ulcerative Colitis
Bruggeling CE, te Groen M, Garza DR, van Heeckeren tot Overlaer F, Krekels JP, Sulaiman BC, Karel D, Rulof A, Schaaphok AR, Hornikx DL, Nagtegaal ID, Dutilh BE, Hoentjen F, Boleij A |
Journal of Crohn's & colitis | 2023 |
The oral-gut-circulatory axis: from homeostasis to colon cancer
Tortora SC, Agurto MG, Martello LA |
Frontiers in Cellular and Infection Microbiology | 2023 |
Enteric Populations of Escherichia coli are Likely to be Resistant to Phages Due to O Antigen Production.
Berryhill BA, Burke KB, Fontaine J, Brink CE, Harvill MG, Goldberg DA, Konstantinidis KT, Levin BR, Woodworth MH |
bioRxiv : the preprint server for biology | 2023 |
A consortia of clinical E. coli strains with distinct in vitro adherent/invasive properties establish their own co-colonization niche and shape the intestinal microbiota in inflammation-susceptible mice.
Bleich RM, Li C, Sun S, Ahn JH, Dogan B, Barlogio CJ, Broberg CA, Franks AR, Bulik-Sullivan E, Carroll IM, Simpson KW, Fodor AA, Arthur JC |
Microbiome | 2023 |
Immunometabolism in biofilm infection: lessons from cancer
R Mirzaei, N Sabokroo, Y Ahmadyousefi, H Motamedi, S Karampoor |
Molecular Medicine | 2022 |
TP53 Gain-of-Function and Non–Gain-of-Function Mutations Are Differentially Associated With Sidedness-Dependent Prognosis in Metastatic Colorectal Cancer
M Pan, C Jiang, P Tse, N Achacoso, S Alexeeff, AV Solorzano, E Chung, W Hu, TG Truong, A Arora, T Sundaresan, JM Suga, S Thomas, LA Habel |
Journal of Clinical Oncology | 2022 |
Reuterin in the healthy gut microbiome suppresses colorectal cancer growth through altering redox balance
H Bell, R Rebernick, J Goyert, R Singhal, M Kuljanin, S Kerk, W Huang, N Das, A Andren, S Solanki, S Miller, P Todd, E Fearon, C Lyssiotis, S Gygi, J Mancias, Y Shah |
Cancer Cell | 2022 |
Bacterial Involvement in Progression and Metastasis of Colorectal Neoplasia
K Seely, A Morgan, L Hagenstein, G Florey, J Small |
Cancers | 2022 |
A Summary of the Sixth International Workshop on Microbiome in HIV Pathogenesis, Prevention, and Treatment
S Sherrill-Mix, M Yang, G Aldrovandi, J Brenchley, F Bushman, R Collman, S Dandekar, N Klatt, L Lagenaur, A Landay, R Paredes, G Tachedjian, J Turpin, S Serrano-Villar, C Lozupone, M Ghosh |
AIDS Research and Human Retroviruses | 2022 |
Colorectal Cancer in Inflammatory Bowel Disease: Mechanisms and Management
S Shah, S Itzkowitz |
Gastroenterology | 2022 |
Polyamines in cancer: integrating organismal metabolism and antitumour immunity
C Holbert, M Cullen, R Casero, T Stewart |
Nature Reviews Cancer | 2022 |
The Mycobiome: Cancer Pathogenesis, Diagnosis, and Therapy
Gamal A, Elshaer M, Alabdely M, Kadry A, McCormick TS, Ghannoum M |
Cancers | 2022 |
The appendix‐mucosal immunity and tolerance in the gut: consequences for the syndromes of appendicitis and its epidemiology
de Costa A |
ANZ Journal of Surgery | 2022 |
Human colon cancer-derived Clostridioides difficile strains drive colonic tumorigenesis in mice
Drewes JL, Chen J, Markham NO, Knippel RJ, Domingue JC, Tam AJ, Chan JL, Kim L, McMann M, Stevens C, Dejea CM, Tomkovich S, Michel J, White JR, Mohammad F, Campodónico VL, Heiser CN, Wu X, Wu S, Ding H, Simner P, Carroll K, Shrubsole MJ, Anders RA, Walk ST, Jobin C, Wan F, Coffey RJ, Housseau F, Lau KS, Sears CL |
Cancer Discovery | 2022 |
Genetic and epigenetic dependencies in colorectal cancer development
Parmar S, Easwaran H |
Gastroenterology Report | 2022 |
Common themes in antimicrobial and anticancer drug resistance
Chifiriuc MC, Filip R, Constantin M, Pircalabioru GG, Bleotu C, Burlibasa L, Ionica E, Corcionivoschi N, Mihaescu G |
Frontiers in microbiology | 2022 |
Intestinal microbiota modulates pancreatic carcinogenesis through intratumoral natural killer cells
Yu Q, Newsome RC, Beveridge M, Hernandez MC, Gharaibeh RZ, Jobin C, Thomas RM |
Gut microbes | 2022 |
Inflammation, microbiome and colorectal cancer disparity in African-Americans: Are there bugs in the genetics?
Ahmad S, Ashktorab H, Brim H, Housseau F |
World Journal of Gastroenterology | 2022 |
Colon mucus in colorectal neoplasia and beyond
Loktionov A |
World Journal of Gastroenterology | 2022 |
Construction of a prognostic model of colon cancer patients based on metabolism-related lncRNAs
Li C, Liu Q, Song Y, Wang W, Zhang X |
Frontiers in Oncology | 2022 |
Association between antibiotic consumption and colon and rectal cancer development in older individuals: A territory‐wide study
Cheung KS, Chan EW, Tam A, Wong IO, Seto WK, Hung IF, Wong IC, Leung WK |
Cancer Medicine | 2022 |
The Role of the Microbiome on the Pathogenesis and Treatment of Colorectal Cancer
Yu I, Wu R, Tokumaru Y, Terracina KP, Takabe K |
Cancers | 2022 |
Bacteriophage-mediated manipulations of microbiota in gastrointestinal diseases
El Haddad L, Mendoza JF, Jobin C |
Frontiers in microbiology | 2022 |
Biofilms and Benign Colonic Diseases
Songtanin B, Peterson CJ, Molehin AJ, Nugent K |
International journal of molecular sciences | 2022 |
Cancer as microenvironmental, systemic and environmental diseases: opportunity for transdisciplinary microbiomics science.
Inamura K, Hamada T, Bullman S, Ugai T, Yachida S, Ogino S |
Gut | 2022 |
Exploiting unique features of the gut-brain interface to combat gastrointestinal cancer
Alyssa Schledwitz, Guofeng Xie, Jean-Pierre Raufman |
Journal of Clinical Investigation | 2021 |
Gutting it Out: Developing Effective Immunotherapies for Patients With Colorectal Cancer
CM Gorgulho, A Krishnamurthy, A Lanzi, J Galon, F Housseau, R Kaneno, MT Lotze |
Journal of immunotherapy (Hagerstown, Md. : 1997) | 2021 |
Microbial-Driven Immunological Memory and Its Potential Role in Microbiome Editing for the Prevention of Colorectal Cancer
L Campillo-Gimenez, D Rios-Covian, J Rivera-Nieves, H Kiyono, H Chu, PB Ernst |
Frontiers in Cellular and Infection Microbiology | 2021 |
Mapping the colorectal tumor microbiota
CL Murphy, M Barrett, P Pellanda, S Killeen, M McCourt, E Andrews, MO Riordain, F Shanahan, P OToole |
Gut microbes | 2021 |
A Phase 1b Safety Study of SER-287, a Spore-Based Microbiome Therapeutic, for Active Mild to Moderate Ulcerative Colitis
MR Henn, EJ OBrien, L Diao, BG Feagan, WJ Sandborn, C Huttenhower, JR Wortman, BH McGovern, S Wang-Weigand, DI Lichter, M Chafee, CB Ford, P Bernardo, P Zhao, S Simmons, AD Tomlinson, DN Cook, RJ Pomerantz, BK Misra, JG Auninš, M Trucksis |
Gastroenterology | 2021 |
Microbiota triggers STING-type I IFN-dependent monocyte reprogramming of the tumor microenvironment
KC Lam, RE Araya, A Huang, Q Chen, MD Modica, RR Rodrigues, A Lopès, SB Johnson, B Schwarz, E Bohrnsen, AP Cogdill, CM Bosio, JA Wargo, MP Lee, RS Goldszmid |
Cell | 2021 |
Host/microbiota interactions in health and diseases—Time for mucosal microbiology!
N Daniel, E Lécuyer, B Chassaing |
Mucosal Immunology | 2021 |
Immunity, immunotherapy, and rectal cancer: A clinical and translational science review
EE Otegbeye, JB Mitchem, H Park, AA Chaudhuri, H Kim, MG Mutch, MA Ciorba |
Translational research : the journal of laboratory and clinical medicine | 2021 |
“Driver-passenger” bacteria and their metabolites in the pathogenesis of colorectal cancer
M Avril, RW DePaolo |
Gut microbes | 2021 |
Mucosal Biofilms Are an Endoscopic Feature of Irritable Bowel Syndrome and Ulcerative Colitis
M Baumgartner, M Lang, H Holley, D Crepaz, B Hausmann, P Pjevac, D Moser, F Haller, F Hof, A Beer, E Orgler, A Frick, V Khare, R Evstatiev, S Strohmaier, C Primas, W Dolak, T Köcher, K Klavins, T Rath, MF Neurath, D Berry, A Makristathis, M Muttenthaler, C Gasche |
Gastroenterology | 2021 |
Gastrointestinal biofilms in health and disease
JP Motta, JL Wallace, AG Buret, C Deraison, N Vergnolle |
Nature Reviews Gastroenterology & Hepatology | 2021 |
Microbiome or Infections: Amyloid-Containing Biofilms as a Trigger for Complex Human Diseases
AL Miller, S Bessho, K Grando, Ç Tükel |
Frontiers in immunology | 2021 |
Mycobiome and Cancer: What Is the Evidence?
N Vallianou, D Kounatidis, GS Christodoulatos, F Panagopoulos, I Karampela, M Dalamaga |
Cancers | 2021 |
Colorectal Tumour Mucosa Microbiome Is Enriched in Oral Pathogens and Defines Three Subtypes That Correlate with Markers of Tumour Progression
B Zwinsová, VA Petrov, M Hrivňáková, S Smatana, L Micenková, N Kazdová, V Popovici, R Hrstka, R Šefr, B Bencsiková, L Zdražilová-Dubská, V Brychtová, R Nenutil, P Vídeňská, E Budinská |
Cancers | 2021 |
Fusobacterium nucleatum Acts as a Pro-carcinogenic Bacterium in Colorectal Cancer: From Association to Causality
S Wang, Y Liu, J Li, L Zhao, W Yan, B Lin, X Guo, Y Wei |
Frontiers in Cell and Developmental Biology | 2021 |
Penicillin disrupts mitochondrial function and induces autophagy in colorectal cancer cell lines
F Hu, Y Wu, C Liu, Y Zhu, S Ye, , W Cui, S Bu |
Oncology Letters | 2021 |
The Cancer Microbiome: Recent Highlights and Knowledge Gaps
RJ Knippel, JL Drewes, CL Sears |
Cancer Discovery | 2021 |
Fusobacterium nucleatum secretes amyloid‐like FadA to enhance pathogenicity
Q Meng, Q Gao, S Mehrazarin, K Tangwanichgapong, Y Wang, Y Huang, Y Pan, S Robinson, Z Liu, A Zangiabadi, R Lux, PN Papapanou, XE Guo, H Wang, LE Berchowitz, YW Han |
EMBO reports | 2021 |
Shining a Light on Colibactin Biology
MW Dougherty, C Jobin |
Toxins | 2021 |
‘Statistical Irreproducibility’ Does Not Improve with Larger Sample Size: How to Quantify and Address Disease Data Multimodality in Human and Animal Research
AR Basson, F Cominelli, A Rodriguez-Palacios |
Journal of Personalized Medicine | 2021 |
Microbiome Analysis of More Than 2,000 NHS Bowel Cancer Screening Programme Samples Shows the Potential to Improve Screening Accuracy
C Young, HM Wood, AF Balaguer, D Bottomley, N Gallop, L Wilkinson, SC Benton, M Brealey, C John, C Burtonwood, KN Thompson, Y Yan, JH Barrett, EJ Morris, C Huttenhower, P Quirke |
Clinical cancer research | 2021 |
The colorectal cancer-associated faecal microbiome of developing countries resembles that of developed countries
C Young, HM Wood, RA Seshadri, PV Nang, C Vaccaro, LC Melendez, M Bose, MV Doi, TA Piñero, CT Valladares, J Arguero, AF Balaguer, KN Thompson, Y Yan, C Huttenhower, P Quirke |
Genome Medicine | 2021 |
A crate of Pandora: do amyloids from bacteria promote Alzheimer’s disease?
VT Nguyen, K Endres |
NEURAL REGEN RES | 2021 |
Biofilm Formation and Virulence of Shigella flexneri Are Modulated by pH of Gastrointestinal Tract
IL Chiang, Y Wang, S Fujii, BD Muegge, Q Lu, PI Tarr, TS Stappenbeck, IE Brodsky |
Infection and immunity | 2021 |
Microbiota-Immune Interactions in Ulcerative Colitis and Colitis Associated Cancer and Emerging Microbiota-Based Therapies
J Popov, V Caputi, N Nandeesha, DA Rodriguez, N Pai |
International journal of molecular sciences | 2021 |
Mucosa-Associated Escherichia coli in Colorectal Cancer Patients and Control Subjects: Variations in the Prevalence and Attributing Features
R Nouri, A Hasani, KM Shirazi, MR Alivand, B Sepehri, S Sotoudeh, F Hemmati, A Fattahzadeh, B Abdinia, MA Rezaee, T Chen |
The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie médicale / AMMI Canada | 2021 |
Antibiotic Use Impacts Colorectal Cancer: A Double-Edged Sword by Tumor Location?
J Zhang, C Sears |
JNCI Journal of the National Cancer Institute | 2021 |
Immune Responses Vary in Preinvasive Colorectal Lesions by Tumor Location and Histology
K Wallace, G Nahas, C Bookhout, J Thaxton, D Lewin, N Nikolaishvili-Feinberg, S Cohen, J Brazeal, E Hill, J Wu, J Baron, A Alekseyenko |
Cancer prevention research (Philadelphia, Pa.) | 2021 |
The Role of Microbiota in Gastrointestinal Cancer and Cancer Treatment – Chance or Curse?
A Smet, J Kupcinskas, A Link, G Hold, J Bornschein |
CMGH Cellular and Molecular Gastroenterology and Hepatology | 2021 |
Genomic and functional characterization of a mucosal symbiont involved in early-stage colorectal cancer
M Kordahi, I Stanaway, M Avril, D Chac, M Blanc, B Ross, C Diener, S Jain, P McCleary, A Parker, V Friedman, J Huang, W Burke, S Gibbons, A Willis, R Darveau, W Grady, C Ko, R DePaolo |
Cell Host & Microbe | 2021 |
Recent progress in analyzing the spatial structure of the human microbiome: distinguishing biogeography and architecture in the oral and gut communities
Adade EE, Al Lakhen K, Lemus AA, Valm AM |
2021 | |
Bacterial Biofilm and its Role in the Pathogenesis of Disease
LK Vestby, T Grønseth, R Simm, LL Nesse |
Antibiotics | 2020 |
Host–microbiota maladaptation in colorectal cancer
A Janney, F Powrie, EH Mann |
Nature | 2020 |
Resolving the Paradox of Colon Cancer Through the Integration of Genetics, Immunology, and the Microbiota
M Fidelle, S Yonekura, M Picard, A Cogdill, A Hollebecque, MP Roberti, L Zitvogel |
Frontiers in immunology | 2020 |
Relationship of the Esophageal Microbiome and Tissue Gene Expression and Links to the Oral Microbiome: A Randomized Clinical Trial
MK Annavajhala, M May, G Compres, DE Freedberg, R Graham, S Stump, J Que, T Korem, AC Uhlemann, JA Abrams |
Clinical and Translational Gastroenterology | 2020 |
Human Colon Mucosal Biofilms and Murine Host Communicate via Altered mRNA and microRNA Expression during Cancer
S Tomkovich, RZ Gharaibeh, CM Dejea, JL Pope, J Jiang, K Winglee, J Gauthier, RC Newsome, Y Yang, AA Fodor, TD Schmittgen, CL Sears, C Jobin, DW Cleary |
mSystems | 2020 |
Clinically adaptable polymer enables simultaneous spatial analysis of colonic tissues and biofilms
MC Macedonia, JL Drewes, NO Markham, AJ Simmons, JT Roland, PN Vega, CR Scurrah, RJ Coffey, MJ Shrubsole, CL Sears, KS Lau |
npj Biofilms and Microbiomes | 2020 |
Host responses to mucosal biofilms in the lung and gut
JC Domingue, JL Drewes, CA Merlo, F Housseau, CL Sears |
Mucosal Immunology | 2020 |
The Cancer Microbiome: Distinguishing Direct and Indirect Effects Requires a Systemic View
JB Xavier, VB Young, J Skufca, F Ginty, T Testerman, AT Pearson, P Macklin, A Mitchell, I Shmulevich, L Xie, JG Caporaso, KA Crandall, NL Simone, F Godoy-Vitorino, TJ Griffin, KL Whiteson, HH Gustafson, DJ Slade, TM Schmidt, MR Walther-Antonio, T Korem, BJ Webb-Robertson, MP Styczynski, WE Johnson, C Jobin, JM Ridlon, AY Koh, M Yu, L Kelly, JA Wargo |
Trends in Cancer | 2020 |
Does the Gut Microbiota Modulate Host Physiology through Polymicrobial Biofilms?
J Yang, Y Yang, M Ishii, M Nagata, W Aw, N Obana, M Tomita, N Nomura, S Fukuda |
Microbes and Environments | 2020 |
Crypt residing bacteria and proximal colonic carcinogenesis in a mouse model of Lynch syndrome
M Lang, M Baumgartner, A Rożalska, A Frick, A Riva, M Jarek, D Berry, C Gasche |
International Journal of Cancer | 2020 |
Oral antibiotic use and chronic disease: long-term health impact beyond antimicrobial resistance and Clostridioides difficile
J Queen, J Zhang, CL Sears |
Gut microbes | 2020 |
Microbiome in cancer progression and therapy
NV Andreeva, RR Gabbasova, SI Grivennikov |
Current Opinion in Microbiology | 2020 |
Antibiotics, cancer risk and oncologic treatment efficacy: a practical review of the literature
Moises S Martins Lopes, Larissa M Machado, Pedro A Ismael Amaral Silva, Angel A Tome Uchiyama, Cheng T Yen, Eliza D Ricardo, Taciana S Mutao, Jefferson R Pimenta, Denis S Shimba, Rodrigo M Hanriot, Renata D Peixoto |
ecancermedicalscience | 2020 |
Roles of the Polyphenol–Gut Microbiota Interaction in Alleviating Colitis and Preventing Colitis-Associated Colorectal Cancer
Y Zhao, Q Jiang |
Advances in Nutrition | 2020 |
Targeting Gut Microbial Biofilms—A Key to Hinder Colon Carcinogenesis?
SS Chew, LT Tan, JW Law, P Pusparajah, BH Goh, NS Mutalib, LH Lee |
Cancers | 2020 |
Colonization of Mice With Amoxicillin-Associated Klebsiella variicola Drives Inflammation via Th1 Induction and Treg Inhibition
H Lin, Q Wang, L Liu, Z Chen, R Das, Y Zhao, D Mao, Y Luo |
Frontiers in microbiology | 2020 |
In sickness and health: Effects of gut microbial metabolites on human physiology
RW Glowacki, EC Martens, LJ Knoll |
PLoS pathogens | 2020 |
Microbiota Effects on Carcinogenesis: Initiation, promotion and progression
Lopez LR, Bleich RM, Arthur JC |
Annual Review of Medicine | 2020 |
Inflammation and Cancer: Triggers, Mechanisms, and Consequences
FR Greten, SI Grivennikov |
Immunity | 2019 |
Zerumbone Suppresses Enterotoxigenic Bacteroides fragilis Infection-Induced Colonic Inflammation through Inhibition of NF-κΒ
S Hwang, M Jo, JE Hong, CO Park, CG Lee, M Yun, KJ Rhee |
International journal of molecular sciences | 2019 |
Conceptual Development of Immunotherapeutic Approaches to Gastrointestinal Cancer
BA Abolarinwa, RB Ibrahim, YH Huang |
International journal of molecular sciences | 2019 |
Impact of the Food Additive Titanium Dioxide (E171) on Gut Microbiota-Host Interaction
G Pinget, J Tan, B Janac, NO Kaakoush, AS Angelatos, J O'Sullivan, YC Koay, F Sierro, J Davis, SK Divakarla, D Khanal, RJ Moore, D Stanley, W Chrzanowski, L Macia |
Frontiers in Nutrition | 2019 |
Gut Microbiome: Profound Implications for Diet and Disease
RD Hills, BA Pontefract, HR Mishcon, CA Black, SC Sutton, CR Theberge |
Nutrients | 2019 |
Biofilms 2018: a Diversity of Microbes and Mechanisms
C Fuqua, A Filloux, JM Ghigo, KL Visick, G O'Toole |
Journal of bacteriology | 2019 |
Oral Bacteria and Intestinal Dysbiosis in Colorectal Cancer
I Koliarakis, I Messaritakis, TK Nikolouzakis, G Hamilos, J Souglakos, J Tsiaoussis |
International journal of molecular sciences | 2019 |
Intestinal microbiota and colorectal carcinoma: Implications for pathogenesis, diagnosis, and therapy
A Montalban-Arques, M Scharl |
EBioMedicine | 2019 |
The Role of the Gut Microbiota in Colorectal Cancer Causation
Alhinai, Walton, Commane |
International journal of molecular sciences | 2019 |